Historical record - last NADAC effective date: 2/21/2024
Product Information
ONDANSETRON 4 MG/5 ML SOLUTION is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.2901 per ML under NDC 51672409103. Its NADAC has been published 535 times since Nov 28, 2013.
FDA first approved this application on Nov 30, 2007.
Strength
4 mg/5mL
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672409103
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
2/21/2024
Active Ingredients
ONDANSETRON HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077009FDA Approved
11/30/2007
On Market Since
11/30/2007
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON 4 MG/5 ML SOLUTION has been published 535 times since Nov 28, 2013, and over the history we have for it it has declined 63.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2901 per ML |
|---|---|
| All-time high | $0.9467 (Feb 12, 2014) |
| All-time low | $0.2213 (Mar 22, 2023) |
| Median price | $0.2978 |
| Average price | $0.4184 |
| Largest weekly change | -22.3% (Sep 17, 2014) |
| Weeks tracked | 535 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+17.8%
5Y
+8.2%
All
-63.9%
Last surveyed Feb 21, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ondansetron hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ondansetron hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON 4 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON 4 MG/5 ML SOLUTION, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.2901 per ML (NDC 51672409103), effective Feb 21, 2024.
How has the price of ONDANSETRON 4 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for ONDANSETRON 4 MG/5 ML SOLUTION has declined 63.9%. It has been tracked across 535 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ONDANSETRON 4 MG/5 ML SOLUTION?
Since Nov 28, 2013, the NADAC for ONDANSETRON 4 MG/5 ML SOLUTION has ranged from a low of $0.2213 (Mar 22, 2023) to a high of $0.9467 (Feb 12, 2014), with a median of $0.2978 per ML.
Are there cheaper alternatives to ONDANSETRON 4 MG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of ONDANSETRON 4 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ONDANSETRON 4 MG/5 ML SOLUTION?
ONDANSETRON 4 MG/5 ML SOLUTION (NDC 51672409103) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.